17 research outputs found

    EVALUASI APLIKASI PENGOLAH DATA UNIT HEMODIALISIS RUMAH SAKIT DI JAWA TIMUR

    Get PDF
    Hasil Plagiasi Artikel Evaluasi Aplikasi Pengolah Data Unit Hemodialisis Rumah Sakit Di Jawa Timu

    Model Aplikasi Pengukuran Kualitas Pelayanan Melalui Pengukuran Kualitas Pasien Hemodialisis

    Get PDF
    Hasil cek plagiasi artikel Model Aplikasi Pengukuran Kualitas Pelayanan Melalui Pengukuran Kualitas Pasien Hemodialisi

    Measuring The Quality of Renal Care Using Information System Design: An Early Warning System to Improve Health Care Quality

    Get PDF
    Hasil Plagiasi artikel Measuring The Quality of Renal Care Using Information System Design: An Early Warning System to Improve Health Care Qualit

    Paricalcitol For CKD-MBD Associated With Secondary Hyperparathyroidism: A Case Series Focus On TRAP5b, b-ALP, and DKK-1

    Get PDF
    Chronic kidney disease (CKD) lead to secondary hyperparathyroidism (sHPT) that caused by phosphate retention and hypocalcemia. This condition known as mineral and bone disorder (CKD-MBD). The increase in parathyroid hormone would increase bone turnover that result in an increased risk of bone fractures, and vascular calcification. These will increase the levels of tartrate-resistant acid phosphatase 5b (TRAP5b), and bone-specific alkaline phosphatase (b-ALP), which is a marker of bone turnover, and also dickkopf-related protein 1 (DKK-1), which is an inhibitor of the Wnt pathway. Secondary hyperparathyroidism in CKD also caused by calcitriol deficiency. Paricalcitol is a synthetic calcitrol analogue used to reduce parathyroid hormone (iPTH) with minimal calcemic and phosphatemic activity. Vitamin D receptor activation by paricalcitol will decrease TRAP5b, b-ALP, and DKK-1. In this study we reported 9 cases of CKD-MBD with Hemodialysis (HD) and associated with sHPT. Four of nine cases received 5μg paricalcitol every HD (twice a week) while the others five is not. Level of iPTH, phosphate, calcium, TRAP5b, b-ALP, and DKK-1 were measured before initiation of study and after three months treatment. According to this study, the paricalcol administration suppresses the increase in iPTH level, bone turnover and vascular calcification showed by decreasing or supresses the increase b-ALP, TRAP5b, DKK-1  leves without increasing calcium and phosphate levels

    Health Related Quality of Life in Life Hemodialysis Patients : A Single center Study

    Get PDF
    Cek Plagiasi dari artikel Health Related Quality of Life in Life Hemodialysis Patients : A Single center Stud

    Understanding students’ continued use of electronic medical records in hospital: task technology to performance chain approach

    Get PDF
    One of the main goals of research on information systems is to help end users and organizations use information technology effectively. Fieldwork practice trains students to apply their knowledge and work skills based on the standards of the health ministry in electronic medical record regulations. This activity also prepares students to live in their health information management profession. This study examined the willingness and ability to use electronic medical records in hospitals to determine how well students understand electronic medical records and what influences their use. This study was conducted at a hospital in Mojokerto, East Java, where students practice fieldwork. An institutional-based crosssectional study was conducted to assess the acceptability of the EMR system among students at Mojokerto Hospital from July 1-31st, 2022. The sampling method used simple random sampling of 136. A structured questionnaire was adopted from the previous studies. The questionnaire consists of 16 questions from the TTF, the expected consequences of use (COU), Facilitating Condition (FC), utilization (UI), and Performance Impact (PI) constructs. Data were analyzed using SmartPLS version 3.0. The result is that Task-technology fit is associated with the expected consequences of use (P=0.00), Consequences of Use (COU) are associated with Utilization (P=0.000), and the Facilitating condition is related to Utilization (P=0.00). We can conclude that task technology fit is indirectly associated with Utilization because of the Consequences of Use (COU). Task-technology fit, and Utilization does not affect the performance impact. This study can continue by testing the construct variables by the students on the field trips and by healthcare providers such as nurses and doctors

    Comparison of Asymmetric Dimethylarginine Levels Between Stages Three, Four, and Five Non-dialysis of Chronic Kidney Disease

    Get PDF
    Aim: to determine the differences of ADMA level between stages 3, 4, and 5 non-dialysis of chronic kidney disease (CKD) patients at Outpatient Nephrology Clinic, Dr. Soetomo Hospital. Methods: a cross-sectional study was conducted on stage 3, 4, and 5 non-dialysis CKD patients at Outpatient Nephrology Clinic, Dr. Soetomo Hospital, Surabaya from January to February 2015. Stages of CKD were determined based on GFR estimation according to 4-variable MDRD formula. Statistical analysis of differences in the levels of ADMA in three subject groups use one-way ANOVA test. Results:seventy-five patients were included in the study. Each group consisted of 25 patients stage 3, 4, and, 5 non-dialysis patients. Mean age of stage 3, stage 4, and stage 5 non-dialysis CKD patients were respectively 57.12 years, 54.80 years and 53.68 years. The mean levels of ADMA in stage 3, stage 4, and 5 were 0.62 (0.11) IU/mL, 0.72 (0.16) IU/mL, and 0.73 (0.18) IU/mL respectively. Analysis of the differences between the groups showed significant differences in ADMA levels (p=0.04), with the highest difference between stage 3 and stage 5. Conclusion:comparison of ADMA levels showed significant differences between CKD stages and the level tends to be higher along with increase severity of CKD stages

    Comparison of high-sensitivity C-reactive Protein Level between chronic kidney disease stage

    Get PDF
    Aim : This research is to evaluate the hs-CRP level comparison between CKD stages in Dr. Soetomo General Hospital Surabaya. Methods: An analytic observational cross-sectional study, evaluating the differences of hs-CRP level between CKD stages in 72 patients (mean age 55.49±7.62 years, the ratio between male:female was 1:1.48, mean BMI 24.18±3.64 kg/m2, 36.11% diabetics, 43.05% on ACEI/ARB, 29.16% on statin), recruited from Nephrology Outpatient Clinic, Dr Soetomo General Hospital, Surabaya, from January to May 2014. The stages were stratified according to the MDRD formula. Results: The mean hs-CRP of CKD stage 3 was 2.29±2.86, stage 4 was 2.48 ± 2.19, and non-dialysis stage 5 was 2.09 ± 2.54. The analysis using Kruskal-Wallis test showed no significant differences among patients with CKD stage 3, stage 4, and non-dialysis stage 5 (median 1.25 vs 1.80 vs 1.05 mg/L; p=0.430). No significant differences of the serum hs-CRP level were detected between diabetics and non diabetics in stage 3, 4, and non-dialysis stage 5 (p=0.673 vs 0.666 vs 0.138); between patients with and without ACEI/ARB treatment (p=0.610 vs 0.649 vs 0.671); and between patients with and without statin treatment (p=0.852 vs 0.341 vs 0.309). Conclusion: The elevation of serum hs-CRP level can not indicate the decline of kidney function, but it still needs further investigations

    Peer Review: Model Aplikasi Pengukuran Kualitas Pelayanan Melalui Pengukuran Kualitas Pasien Hemodialisis

    Get PDF
    Hasil Peer Review: Model Aplikasi Pengukuran Kualitas Pelayanan Melalui Pengukuran Kualitas Pasien Hemodialisi

    Peer Review : Evaluasi Aplikasi Pengolah Data Unit Hemodialisi Rumah Sakit Di Jawa Timur

    Get PDF
    Peer Review : Evaluasi Aplikasi Pengolah Data Unit Hemodialisi Rumah Sakit Di Jawa Timu
    corecore